MRI substudy
TED · 550167-2026Award noticeawardedNo deadline given
CPV codes
73000000 Research & development services85148000 Health & social work servicesDescription
PRImus-AD is a Phase II clinical trial investigating the efficacy and safety of an innovative drug in patients with mild cognitive impairment or mild Alzheimer's dementia.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-01 | Evaluation of trials with work orientated introduction programme 2026-2029 - INTROFAM | Integrerings- og mangfoldsdirektoratet (IMDi) NO | 85% |
| 2026-05-07 | QMMO26-4061 - delivery of a digital tool for remote assessment to detect cognitive decline and dementia in a population-based research cohort representative of the Flemish population aged over 45 | — BE | 84% |
| 2026-05-15 | Medicines and ampoules | PHI University Clinic for Surgical Diseases St. Naum Ohridski-Skopje MK | 84% |
| 2026-07-17 | Supply of primers, probes, reagents and consumables for PCR and DNA/RNA analysis | European Commission, DG JRC - Joint Research Centre IT | 84% |
| 2026-07-09 | Market consultation preclinical MRI system - AMICE network | Radboud universitair medisch centrum NL | 84% |
| 2026-05-27 | A09AA02 MULTIENZYMOVÉ PŘÍPRAVKY (LIPASA, PROTEASA APOD.) - KREON | Fakultní nemocnice u sv. Anny v Brně CZ | 83% |